Literature DB >> 23768075

Effects of dose-delivery time structure on biological effectiveness for therapeutic carbon-ion beams evaluated with microdosimetric kinetic model.

Taku Inaniwa1, Masao Suzuki, Takuji Furukawa, Yuki Kase, Nobuyuki Kanematsu, Toshiyuki Shirai, Roland B Hawkins.   

Abstract

Treatment plans of carbon-ion radiotherapy have been made on the assumption that the beams are delivered instantaneously irrespective to the dose delivery time as well as the interruption time. The advanced therapeutic techniques such as a hypofractionation and a respiratory gating usually require more time to deliver a fractioned dose than conventional techniques. The purpose of this study was to investigate the effects of dose-delivery time structure on biological effectiveness in carbon-ion radiotherapy. The rate equations defined in the microdosimetric kinetic model (MKM) for primary lesions caused in the DNA were reanalyzed and applied to continuous or interrupted irradiation with therapeutic carbon-ion beams. The rate constants characterizing the time of the primary nonlethal lesions to repair or to convert to lethal lesion were experimentally determined for human salivary gland (HSG) tumor cells. Treatment plans were made for a patient case on the assumption that the beam is delivered instantaneously. The RBE weighted absorbed doses of 2.65, 3.45 and 6.86 Gy (RBE) was prescribed to the target. These plans were recalculated by varying the dose delivery time and the interruption time ranging from 1-60 min based on the MKM with the determined parameters. The sum of rate constants for nonlethal lesion to repair a and to convert to lethal lesion c, (a + c), is 2.19 ± 0.40 h⁻¹. The biological effectiveness in the target decreases with the dose delivery time T in continuous irradiation compared to the planned one due to the repair of nonlethal lesions during the irradiation. The biological effectiveness in terms of equivalent acute dose decreases to 99.7% and 96.4% for T = 3 and 60 min in 2.65 Gy (RBE), 99.5% and 94.3% in 4.35 Gy (RBE), and 99.4% and 91.7% in 6.86 Gy (RBE), respectively. For all the cases, the decrease of biological effectiveness is larger at the proximal side with low-LET than the distal side with high-LET. Similar reductions of biological effectiveness with comparable amounts are observed in the interrupted irradiations with prolonged interruption time τ. For the fraction time, i.e., T and/or τ, shorter than 3 min, the decrease of the biological effectiveness with respect to the planned one is less than 1.0%. However, if the fraction time prolongs to 30 min or longer, the biological effectiveness is significantly influenced in carbon-ion radiotherapy, especially with high-prescribed doses. These effects, if confirmed by clinical studies, should be considered in designing the carbon-ion treatment planning.
© 2013 by Radiation Research Society

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23768075     DOI: 10.1667/RR3178.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  16 in total

1.  Dose compensation based on biological effectiveness due to interruption time for photon radiation therapy.

Authors:  Daisuke Kawahara; Hisashi Nakano; Akito Saito; Shuichi Ozawa; Yasushi Nagata
Journal:  Br J Radiol       Date:  2020-05-07       Impact factor: 3.039

2.  Generalized stochastic microdosimetric model: The main formulation.

Authors:  F Cordoni; M Missiaggia; A Attili; S M Welford; E Scifoni; C La Tessa
Journal:  Phys Rev E       Date:  2021-01       Impact factor: 2.529

3.  Evaluation of the cell survival curve under radiation exposure based on the kinetics of lesions in relation to dose-delivery time.

Authors:  Yusuke Matsuya; Kaori Tsutsumi; Kohei Sasaki; Hiroyuki Date
Journal:  J Radiat Res       Date:  2014-10-29       Impact factor: 2.724

4.  Model assembly for estimating cell surviving fraction for both targeted and nontargeted effects based on microdosimetric probability densities.

Authors:  Tatsuhiko Sato; Nobuyuki Hamada
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

5.  Validation of the physical and RBE-weighted dose estimator based on PHITS coupled with a microdosimetric kinetic model for proton therapy.

Authors:  Kenta Takada; Tatsuhiko Sato; Hiroaki Kumada; Junichi Koketsu; Hideyuki Takei; Hideyuki Sakurai; Takeji Sakae
Journal:  J Radiat Res       Date:  2018-01-01       Impact factor: 2.724

6.  Modeling cell survival and change in amount of DNA during protracted irradiation.

Authors:  Yusuke Matsuya; Kaori Tsutsumi; Kohei Sasaki; Yuji Yoshii; Takaaki Kimura; Hiroyuki Date
Journal:  J Radiat Res       Date:  2017-05-01       Impact factor: 2.724

7.  Biological dose-enhancement analysis with Monte Carlo simulation for Lipiodol for photon beams.

Authors:  Daisuke Kawahara; Shuichi Ozawa; Hisashi Nakano; Katsumaro Kubo; Takehiro Shiinoki; Tomoki Kimura; Yasushi Nagata
Journal:  Rep Pract Oncol Radiother       Date:  2019-11-08

8.  A Simpler Energy Transfer Efficiency Model to Predict Relative Biological Effect for Protons and Heavier Ions.

Authors:  Bleddyn Jones
Journal:  Front Oncol       Date:  2015-08-11       Impact factor: 6.244

9.  Microdosimetric Modeling of Biological Effectiveness for Boron Neutron Capture Therapy Considering Intra- and Intercellular Heterogeneity in 10B Distribution.

Authors:  Tatsuhiko Sato; Shin-Ichiro Masunaga; Hiroaki Kumada; Nobuyuki Hamada
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

10.  Integrated Modelling of Cell Responses after Irradiation for DNA-Targeted Effects and Non-Targeted Effects.

Authors:  Yusuke Matsuya; Kohei Sasaki; Yuji Yoshii; Go Okuyama; Hiroyuki Date
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.